D. Parums

Pulmonary and Respiratory Medicine · 2006–2023

A researcher in the Science corpus: 2 papers; trusts 19 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Pulmonary and Respiratory Medicine — 132 citations into it
• Physiology — 43 citations into it
• Oncology — 33 citations into it
• Sociology and Political Science — 25 citations into it
• Molecular Biology — 9 citations into it
• General Health Professions — 8 citations into it
• Cardiology and Cardiovascular Medicine — 5 citations into it

Whom D. Parums trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. P. Calverley
2. Bartolome Celli
3. T. Seemungal
4. Alvar Agusti
5. Jorgen Vestbo
6. J. Soriano
7. John R. Hurst
8. J. Wedzicha
9. G. Donaldson
10. David M. Mannino

Papers from D. Parums's perspective

Ordered by how strongly the researchers D. Parums trusts endorse each paper. Same corpus, a different order for every researcher.

1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (American Journal of Respiratory and Critical Care Medicine)
2. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis (Thorax)
3. Systemic manifestations and comorbidities of COPD (European Respiratory Journal)
4. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. (European Respiratory Journal)
5. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. (American Journal of Respiratory and Critical Care Medicine)
6. Gender and chronic obstructive pulmonary disease: why it matters.
7. Epidemiology and costs of chronic obstructive pulmonary disease (European Respiratory Journal)
8. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. (American Journal of Respiratory and Critical Care Medicine)
9. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. (American Journal of Respiratory and Critical Care Medicine)
10. Characterisation of COPD heterogeneity in the ECLIPSE cohort (Respiratory Research)

Their papers

• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023) — 1,417 citations
• Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer. (2006) — 732 citations